![](/img/cover-not-exists.png)
ACTG A5353: A Pilot Study of Dolutegravir Plus Lamivudine for Initial Treatment of Human Immunodeficiency Virus-1 (HIV-1)–infected Participants With HIV-1 RNA
Taiwo, Babafemi O, Zheng, Lu, Stefanescu, Andrei, Nyaku, Amesika, Bezins, Baiba, Wallis, Carole L, Godfrey, Catherine, Sax, Paul E, Acosta, Edward, Haas, David, Smith, Kimberly Y, Sha, Beverly, Van DaLanguage:
english
Journal:
Clinical Infectious Diseases
DOI:
10.1093/cid/cix1083
Date:
December, 2017
File:
PDF, 726 KB
english, 2017